Biologic Drugs With Mechanism of Action: Vascular Endothelial Growth Factor-directed Antibody Interactions
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Vascular Endothelial Growth Factor-directed Antibody Interactions
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | ⤷ Subscribe | ⤷ Subscribe |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | 5,840,299 | ⤷ Subscribe |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | 6,602,503 | ⤷ Subscribe |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | 10,011,856 | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |